Screener
Aclaris Therapeutics ACRS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's asset turnover?
- Aclaris Therapeutics (ACRS) reported asset turnover of 0× in Q2 2026.
- How has Aclaris Therapeutics's asset turnover changed year-over-year?
- Aclaris Therapeutics's asset turnover decreased by 53.5% year-over-year, from 0.1× to 0×.
- What is the long-term trend for Aclaris Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's asset turnover has grown at a -11.7% compound annual growth rate (CAGR), from 0.1× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Aclaris Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude